Five years ago, world record marathon runner Paula Radcliffe found herself living every parent’s worst nightmare. Her ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have improved survival following immunotherapy compared to patients without ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

WELL, AN ASSISTANT PROFESSOR AT THE UNIVERSITY OF NEW MEXICO HAS JUST RECEIVED A GRANT TO CONDUCT MORE RESEARCH ON THE ...

China Walker, 30 of the rising rap duo Cam & China, has passed away after a 2 year battle with a rare and aggressive form of ...

Anixa Biosciences advances CAR T-cell therapy for recurrent ovarian cancer, targeting FSHR with promising safety and efficacy ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when ...

New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with ...

Ovarian cancer in particular ... doesn't have great survival,” said one researcher. “Anything we can do to better understand ...